Page last updated: 2024-09-03

ly 255283 and eicosapentaenoic acid

ly 255283 has been researched along with eicosapentaenoic acid in 1 studies

Compound Research Comparison

Studies
(ly 255283)
Trials
(ly 255283)
Recent Studies (post-2010)
(ly 255283)
Studies
(eicosapentaenoic acid)
Trials
(eicosapentaenoic acid)
Recent Studies (post-2010) (eicosapentaenoic acid)
540157,1711,3043,623

Protein Interaction Comparison

ProteinTaxonomyly 255283 (IC50)eicosapentaenoic acid (IC50)
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))Homo sapiens (human)4
Prostaglandin G/H synthase 2Ovis aries (sheep)7.1
Oxoeicosanoid receptor 1Homo sapiens (human)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, H; Ikeda, H; Ishimura, K; Ono, Y; Sato, Y; Shuto, S; Tansho-Nagakawa, S; Ubagai, T; Unno, Y; Watanabe, M1

Other Studies

1 other study(ies) available for ly 255283 and eicosapentaenoic acid

ArticleYear
Resolvin E1, but not resolvins E2 and E3, promotes fMLF-induced ROS generation in human neutrophils.
    FEBS letters, 2018, Volume: 592, Issue:16

    Topics: Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Inflammation; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Onium Compounds; Reactive Oxygen Species; Receptors, Leukotriene B4; Tetrazoles

2018